推荐同事 机构合作 中文 繁體中文 English 한국어 日本語 Português Español

美国ACCDON公司旗下品牌

021-33361733，021-33632861

chinasupport@letpub.com

登录 注册 新注册优惠

Morphologic spectrum of immunohistochemically characterized clear cell carcinoma of the ovary: a study of 155 cases

D DeLair, E Oliva, M Köbel, A Macias… - … American journal of …, 2011 - journals.lww.com
Establishing a diagnosis of ovarian clear cell carcinoma (O-CCC) can be subject to significant
interobserver variation. Accurately diagnosing this tumor is important because of its chemoresistance
and reported association with Lynch syndrome. The spectrum of the morphologic features ...
Cited by 6 - Related articles - All 5 versions

The activity of trabectedin as a single agent or in combination with everolimus for clear cell carcinoma of the ovary

S Mabuchi, T Hisamatsu, C Kawase… - Clinical Cancer …, 2011 - AACR
Experimental Design: Using 6 human ovarian cancer cell lines (3 CCC and 3 serous
adenocarcinomas), the antitumor effects of trabectedin were examined in vitro, and we compared
its activity according to histology. We next examined the antitumor activity of trabectedin in ...
Related articles - All 3 versions

Rsf-1 (HBXAP) expression is associated with advanced stage and lymph node metastasis in ovarian clear cell carcinoma

D Maeda, X Chen, B Guan… - International Journal …, 2011 - journals.lww.com
... Ovarian clear cell carcinoma (CCC) represents less than 10% of ovarian cancers in the United
States, but occurs more frequently in Asian women ... marker of reduced disease-specific survival
in CCC, but not in high-grade serous or endometrioid carcinomas of the ovary ( 11 ). ...
Cited by 1 - Related articles - All 5 versions

Exploring palliative treatment outcomes in women with advanced or recurrent ovarian clear cell carcinoma

J Al-Barrak, JL Santos, A Tinker, P Hoskins… - Gynecologic …, 2011 - Elsevier
... Research highlights. ► Among patients with advanced clear cell carcinoma of ovary
(CCC), chemotherapy provides a modest palliative benefits and careful monitoring
is necessary in order to determine the benefit to risk ratio. ...
Related articles - All 2 versions

Weekly administration of temsirolimus for heavily pretreated patients with clear cell carcinoma of the ovary: a report of six cases

M Takano, Y Kikuchi, K Kudoh, T Goto… - International Journal of …, 2011 - Springer
Abstract Clear cell carcinoma (CCC) of the ovary is well-known to be chemotherapy resistant
compared with other histologic subtypes. An inhibitor against the mam- malian target of
rapamycin, temsirolimus (TEM) has been reported to be effective in renal CCC. Therefore, ...
Related articles - All 2 versions

联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们

© 2010-2024 中国: LetPub上海分公司    网站备案号：沪ICP备10217908号-1    沪公网安备号：31010402006960

增值电信业务经营许可证：沪B2-20211595

礼翰商务信息咨询（上海）有限公司      办公地址：上海市徐汇区漕溪北路88号圣爱大厦1803室

United States: Tel: 1-781-202-9968 Address: 400 5th Ave, Suite 530, Waltham, Massachusetts 02451